WHO says GLP-1 medicines alone won’t reverse obesity or improve metabolic health; issues its first guidelines for use

The World Health Organization (WHO) has for the first time issued guidelines on the use of Glucagon-Like Peptide-1 or GLP-1 therapies for treating obesity. This is a major move at a time when the sales of these drugs are rapidly growing across…